Capricor Therapeutics (CAPR) Current Leases (2021 - 2025)
Historic Current Leases for Capricor Therapeutics (CAPR) over the last 5 years, with Q3 2025 value amounting to $120094.0.
- Capricor Therapeutics' Current Leases fell 8523.98% to $120094.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $120094.0, marking a year-over-year decrease of 8523.98%. This contributed to the annual value of $834799.0 for FY2024, which is 1143.85% up from last year.
- According to the latest figures from Q3 2025, Capricor Therapeutics' Current Leases is $120094.0, which was down 8523.98% from $849505.0 recorded in Q2 2025.
- In the past 5 years, Capricor Therapeutics' Current Leases registered a high of $849505.0 during Q2 2025, and its lowest value of $120094.0 during Q3 2025.
- In the last 5 years, Capricor Therapeutics' Current Leases had a median value of $718496.0 in 2023 and averaged $673710.4.
- Its Current Leases has fluctuated over the past 5 years, first skyrocketed by 6331.1% in 2022, then plummeted by 8523.98% in 2025.
- Quarter analysis of 5 years shows Capricor Therapeutics' Current Leases stood at $417632.0 in 2021, then surged by 63.31% to $682039.0 in 2022, then increased by 9.83% to $749112.0 in 2023, then increased by 11.44% to $834799.0 in 2024, then plummeted by 85.61% to $120094.0 in 2025.
- Its Current Leases was $120094.0 in Q3 2025, compared to $849505.0 in Q2 2025 and $842101.0 in Q1 2025.